Elanco Director Paul Herendeen Buys 10,000 Shares in $236K Transaction
Paul Herendeen, a director at Elanco Animal Health (ELAN), purchased 10,000 shares of the company's stock on August 7, 2026, for approximately $236,800. The transaction was disclosed via an SEC Form 4 filing and reflects confidence in the firm’s future performance despite its recent financial challenges. Elanco reported a net loss of $199 million over the trailing twelve months but generated $5 billion in revenue during that period. Shares have returned about 34% over the past year, outperforming the S&P 500's roughly 20%. The purchase price per share was higher than Elanco’s closing stock price on the day of the transaction. Herendeen now holds a total of 111,687 shares directly in his portfolio following this acquisition. His stake represents approximately 0.0224% ownership and is valued at around $2.4 million based on market close prices.
Tickers: $ELAN